Endovascular Recanalization for Nonacute Carotid Artery Occlusion: A Nationwide Registry‐Based Cohort Study

Author:

Hou Chao1,Shi Xuan1,Huo Shuxian1,Yin Qin1,Huang Xianjun2,Sun Wen3,Xiao Guodong4,Yang Yong5,Chen Hongbing6,Li Min7,Du Mingyang8,Han Yunfei1,Fan Xiaobing1,Zhao Qingshi9,Zhu Shuanggen10,Liu Xinfeng13,Ye Ruidong1ORCID

Affiliation:

1. Department of Neurology Affiliated Jinling Hospital Medical School of Nanjing University Nanjing China

2. Department of Neurology The First Affiliated Hospital of Wannan Medical College Wannan Medical College Wuhu China

3. Stroke Center & Department of Neurology Division of Life Sciences and Medicine The First Affiliated Hospital of USTC University of Science and Technology of China Hefei China

4. Department of Neurology and Suzhou Clinical Research Center of Neurological Disease The Second Affiliated Hospital of Soochow University Suzhou China

5. Department of Neurology Guangzhou First People's Hospital School of Medicine South China University of Technology Guangzhou China

6. Department of Neurology and Stroke Center The First Affiliated Hospital Sun Yat‐Sen University Guangzhou China

7. Department of Neurology Jiangsu Province Hospital of Chinese Medicine Nanjing University of Chinese Medicine Nanjing China

8. Cerebrovascular Disease Treatment Center Nanjing Brain Hospital Affiliated to Nanjing Medical University Nanjing China

9. Department of Neurology Affiliated Longhua People's Hospital Southern Medical University (Longhua People's Hospital) Shenzhen China

10. Department of Neurology The Affiliated Central Hospital of Shenzhen Longhua District Guangdong Medical University Shenzhen China

Abstract

Background The management of nonacute symptomatic internal carotid artery occlusion remains unsatisfactory. Endovascular recanalization has been reported to be feasible but associated with a noteworthy risk of postprocedural complications in patients with symptomatic internal carotid artery occlusion. The present study aimed to investigate whether successful recanalization exerts clinical benefits over procedural risks. Methods We analyzed consecutive patients who underwent endovascular treatment of nonacute symptomatic internal carotid artery occlusion in a nationwide prospective registry. The primary outcome was the ipsilateral ischemic stroke recurrence. Other outcomes of interest included all strokes and death during follow‐up, and 30‐day symptomatic intracranial hemorrhage, and all strokes after intervention. Results The final analysis included 511 patients. Endovascular revascularization was successful in 300 patients (58.7%) but failed in 211 patients (41.3%). Patients with successful recanalization had less time from the last ischemic event to the endovascular treatment as compared with patients with failed recanalization (median [interquartile range] days, 18 [12–33] versus 22 [14–50]; P =0.003). Successful recanalization was associated with a higher rate of symptomatic intracranial hemorrhage within 30 days after intervention (odds ratio [OR], 7.99 [95% CI, 1.02–62.39]; P =0.047). Thirty‐day all strokes (OR, 1.91 [95% CI, 0.83–4.40]; P =0.128) and ischemic stroke (OR, 0.90 [95% CI, 0.33–2.46]; P =0.839) did not differ significantly. During a median follow‐up of 37 months, patients with successful recanalization demonstrated a reduced risk of ipsilateral ischemic stroke (adjusted hazard ratio, 0.28 [95% CI, 0.13–0.59]; P <0.001). The 5‐year risk of all strokes and death was likewise lower in patients with successful recanalization (restricted mean survival time difference, 3.77 months [95% CI, 0.16–7.38]; P =0.041). Conclusion Despite an increase in the 30‐day symptomatic intracranial hemorrhage, successful recanalization was associated with reduced long‐term risk of ipsilateral ischemic stroke in patients with symptomatic internal carotid artery occlusion.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3